Literature DB >> 28120431

Central role of the TIR-domain-containing adaptor-inducing interferon-β (TRIF) adaptor protein in murine sterile liver injury.

Katherine J Brempelis1,2, Sebastian Y Yuen2, Nicole Schwarz2, Isaac Mohar2, Ian N Crispe2.   

Abstract

Multiple pathways drive the sterile injury response in the liver; however, it is unclear how the type of cells injured or the mechanism of injury activates these pathways. Here, we use a model of selective hepatocyte death to investigate sterile liver injury. In this model, the TIR-domain-containing adaptor-inducing interferon-β (TRIF) was a central mediator of the resulting intrahepatic inflammatory response that was independent of both upstream Toll-like receptor (TLR) 4 signaling and downstream type I interferon (IFN) signaling. TRIF was required for induction of interleukin (IL)-10, IL-6, and IL-1β cytokines. Conversely, although induction of C-C motif chemokine ligand (CCL) 2 and C-X-C motif chemokine ligand (CXCL) 1 chemokines and up-regulation of chemokine (Ccl2, Ccl7, Cxcl1, Cxcl2, and Cxcl10) and cell-adhesion (intracellular adhesion molecule 1 and vascular cell adhesion molecule 1) genes involved in myeloid cell recruitment was reduced in a majority of TRIF-/- mice, a subset of TRIF-/- mice showed breakthrough inflammation and the ability to induce these genes and proteins, indicating that redundant pathways exist to respond to hepatocyte death. Furthermore, we found that hepatocytes themselves were the main responders to hepatocyte death, increasing transcription of genes involved in myeloid cell recruitment more than either liver sinusoidal endothelial cells or Kupffer cells.
CONCLUSION: Our studies define a TRIF-dependent, TLR4- and type I IFN-independent pathway of sterile liver injury in which hepatocytes are both the targets of damage and the principal responding cell type. (Hepatology 2017;65:1336-1351).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28120431      PMCID: PMC5391172          DOI: 10.1002/hep.29078

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  50 in total

1.  Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury.

Authors:  Jana C Mossanen; Oliver Krenkel; Can Ergen; Olivier Govaere; Anke Liepelt; Tobias Puengel; Felix Heymann; Sandra Kalthoff; Eric Lefebvre; Dirk Eulberg; Tom Luedde; Gernot Marx; Christian P Strassburg; Tania Roskams; Christian Trautwein; Frank Tacke
Journal:  Hepatology       Date:  2016-07-22       Impact factor: 17.425

Review 2.  Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.

Authors:  Yoon Seok Roh; Ekihiro Seki
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 3.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

4.  Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors.

Authors:  Anne-Kathrin Zaiss; Qiang Liu; Gloria P Bowen; Norman C W Wong; Jeffrey S Bartlett; Daniel A Muruve
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

6.  Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.

Authors:  Xiu-Da Shen; Bibo Ke; Yuan Zhai; Feng Gao; Sei-Ichiro Tsuchihashi; Charles R Lassman; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2007-10       Impact factor: 5.799

7.  Isolation of Non-parenchymal Cells from the Mouse Liver.

Authors:  Isaac Mohar; Katherine J Brempelis; Sara A Murray; Mohammad R Ebrahimkhani; I Nicholas Crispe
Journal:  Methods Mol Biol       Date:  2015

8.  Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury.

Authors:  Michael P Holt; LinLing Cheng; Cynthia Ju
Journal:  J Leukoc Biol       Date:  2008-08-19       Impact factor: 4.962

9.  Toll-like receptor signaling and liver fibrosis.

Authors:  Tomonori Aoyama; Yong-Han Paik; Ekihiro Seki
Journal:  Gastroenterol Res Pract       Date:  2010-07-25       Impact factor: 2.260

10.  A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury.

Authors:  Daniela Dal-Secco; Jing Wang; Zhutian Zeng; Elzbieta Kolaczkowska; Connie H Y Wong; Björn Petri; Richard M Ransohoff; Israel F Charo; Craig N Jenne; Paul Kubes
Journal:  J Exp Med       Date:  2015-03-23       Impact factor: 14.307

View more
  4 in total

1.  Precision-cut human liver slice cultures as an immunological platform.

Authors:  Xia Wu; Jessica B Roberto; Allison Knupp; Heidi L Kenerson; Camtu D Truong; Sebastian Y Yuen; Katherine J Brempelis; Marianne Tuefferd; Antony Chen; Helen Horton; Raymond S Yeung; Ian N Crispe
Journal:  J Immunol Methods       Date:  2018-02-01       Impact factor: 2.303

2.  Toll-Like Receptor 4 Mediates Methamphetamine-Induced Neuroinflammation through Caspase-11 Signaling Pathway in Astrocytes.

Authors:  Si-Hao Du; Dong-Fang Qiao; Chuan-Xiang Chen; Si Chen; Chao Liu; Zhoumeng Lin; Huijun Wang; Wei-Bing Xie
Journal:  Front Mol Neurosci       Date:  2017-12-12       Impact factor: 5.639

3.  TRIF as a Novel Modulator of Liver Inflammation and Fibrosis.

Authors:  Natalie J Török
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-22

4.  Response of Human Liver Tissue to Innate Immune Stimuli.

Authors:  Xia Wu; Jessica B Roberto; Allison Knupp; Alexander L Greninger; Camtu D Truong; Nicole Hollingshead; Heidi L Kenerson; Marianne Tuefferd; Antony Chen; David M Koelle; Helen Horton; Keith R Jerome; Stephen J Polyak; Raymond S Yeung; Ian N Crispe
Journal:  Front Immunol       Date:  2022-03-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.